SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
123
Lv3
240 积分
2023-07-03 加入
最近求助
最近应助
互助留言
Perioperative Nivolumab in Resectable Lung Cancer
22天前
已完结
Nivolumab plus Ipilimumab in Microsatellite-Instability–High Metastatic Colorectal Cancer
22天前
已完结
Rational administration sequencing of immunochemotherapy elicits powerful anti-tumor effect
1个月前
已完结
Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea
1个月前
已完结
Multi-organ immune-related adverse events from immune checkpoint inhibitors and their downstream implications: a retrospective multicohort study
1个月前
已完结
FDA Approval Summary: Polatuzumab Vedotin in the First-Line Treatment of Select Large B-cell Lymphomas
3个月前
已完结
The Gut Microbiome and Acute Leukemia: Implications for Early Diagnostic and New Therapies
10个月前
已完结
Scientific Advances and the Evolution of Diagnosis, Subclassification and Treatment of Lymphoma
10个月前
已完结
Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia
11个月前
已完结
An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients
11个月前
已完结
没有进行任何应助
感谢
22天前
感谢
22天前
点赞
1个月前
点赞
1个月前
感谢
1个月前
感谢
10个月前
感谢
10个月前
点赞
11个月前
感谢
11个月前
感谢
11个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论